Alpha DNA Investment Management’s IBM IBM Stock Holding History

Alpha DNA Investment Management’s Portfolio IBM Stock Details IBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-287	Closed	-$36K	–	343
2021 Q1	$36K	Sell	287 -6	-2%	-$718	0.04%	213
2020 Q4	$35K	Buy	+293	New	+$33.9K	0.04%	205

Other funds holding IBM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's IBM Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of IBM (IBM) in Q2 2021, closing a stake of 287 shares — an estimated $36K sold.

Alpha DNA Investment Management first reported a position in IBM in Q4 2020 and held it in 2 quarters. The position peaked at $36K in Q1 2021. 2,216 funds tracked by Wall St. Rank hold IBM as of Q2 2021.

Alpha DNA Investment Management reported no remaining IBM position as of Q2 2021 after selling out during the quarter.
Alpha DNA Investment Management sold 287 IBM shares in Q2 2021, an estimated $36K.
Alpha DNA Investment Management first reported a position in IBM in Q4 2020 and held it in 2 quarters.
Alpha DNA Investment Management's IBM position peaked at $36K in Q1 2021.
2,216 funds tracked by Wall St. Rank held IBM as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.